Maria S Varughese il 24/02/2025

GLP-1 receptor agonist therapy and pregnancy: Evolving and emerging evidence

Clin Med (Lond). 2025 Mar;25(2):100298. doi: 10.1016/j.clinme.2025.100298. Epub 2025 Feb 22.ABSTRACTThe prevalence of type 2 diabetes mellitus (T2DM) and obesity is increasing in young adults, posing significant risks around pregnancy. Obesity also impacts on fertility and the co-existence of polycy

Harriet D Morgan il 19/12/2024

The approach to a pregnancy after bariatric surgery

Clin Med (Lond). 2025 Jan;25(1):100275. doi: 10.1016/j.clinme.2024.100275. Epub 2024 Dec 17.ABSTRACTWith a rising worldwide incidence of obesity, particularly in the young, bariatric surgery offers an effective method of meaningful and sustained weight loss. At present, most bariatric procedures are

Ankita Gupta il 20/10/2024

Determining factors influencing hospital stay for individuals admitted with diabetes-related ketoacidosis - findings from DEKODE length of stay quality improvement project

Clin Med (Lond). 2024 Nov;24(6):100255. doi: 10.1016/j.clinme.2024.100255. Epub 2024 Oct 19.ABSTRACTThere are significant variations in discharge post-diabetes-related ketoacidosis (DKA) hospitalisation, yet there is a paucity of research to understand or minimise the reasons. This quality improveme

Saleem Ansari il 21/04/2024

Time to unshackle the medical treatment of obesity in the NHS

Clin Med (Lond). 2024 May;24(3):100206. doi: 10.1016/j.clinme.2024.100206. Epub 2024 Apr 21.ABSTRACTObesity affects one in four people in the United Kingdom and costs the National Health Service (NHS) ∼£6.5 billion annually. The glucagon-like peptide-1 (GLP-1) receptor analogues, such as once-daily

Mustafa Jalal il 08/12/2023

Are we missing pancreatic exocrine insufficiency in 'at-risk' groups? Prospective assessment of the current practice and yield of faecal elastase testing in patients with diabetes mellitus, HIV and/or high alcohol intake

Clin Med (Lond). 2023 Nov;23(6):588-593. doi: 10.7861/clinmed.2023-0185.ABSTRACTThere is cumulative evidence that pancreatic exocrine insufficiency (PEI) is under-recognised and can occur in patients with 'at-risk' conditions. Thus, we aimed to assess the current practice and yield of requesting fae

Peter Jacob il 31/07/2023

Assessment and management of chronic kidney disease in people living with obesity

Clin Med (Lond). 2023 Jul;23(4):353-356. doi: 10.7861/clinmed.2023-0195.ABSTRACTObesity and chronic kidney disease (CKD) are common and frequently coexisting medical conditions. Already well known to be a risk factor for type 2 diabetes mellitus (T2DM), ischaemic heart disease, stroke, hypertension,

Sheena Gupta il 31/07/2023

Medical management of obesity

Clin Med (Lond). 2023 Jul;23(4):323-329. doi: 10.7861/clinmed.2023-0183.ABSTRACTObesity is a global epidemic that has worsened over the past few decades. It is strongly associated with multiple health conditions, including type 2 diabetes mellitus, cardiovascular diseases, obstructive sleep apnoea,

Caroline J Magri il 31/07/2023

Sleep measures and cardiovascular disease in type 2 diabetes mellitus

Clin Med (Lond). 2023 Jul;23(4):380-386. doi: 10.7861/clinmed.2022-0442.ABSTRACTOBJECTIVE: The objective of this study was to assess whether poor sleep is independently associated with cardiovascular disease in people with type 2 diabetes mellitus (T2DM).METHODS: A cross-sectional study was performe

Eka Melson il 31/07/2023

Future therapies for obesity

Clin Med (Lond). 2023 Jul;23(4):337-346. doi: 10.7861/clinmed.2023-0144.ABSTRACTObesity is a chronic disease associated with increased morbidity and mortality. Bariatric surgery can lead to sustained long-term weight loss (WL) and improvement in multiple obesity-related complications, but it is not

Vivian Lee il 31/07/2023

Introduction to the dietary management of obesity in adults

Clin Med (Lond). 2023 Jul;23(4):304-310. doi: 10.7861/clinmed.2023-0157.ABSTRACTObesity is a multifaceted and complex condition that requires holistic management. It currently affects nearly one in four adults in the UK, with the UK ranked 10th globally for the highest obesity rates. Obesity is proj

Vishnou Mourougavelou il 31/07/2023

Management of hyperglycaemia in people with obesity

Clin Med (Lond). 2023 Jul;23(4):364-371. doi: 10.7861/clinmed.2023-0135.ABSTRACTDiabetes and obesity are closely interlinked. Obesity is a major risk factor for the development of type 2 diabetes mellitus and appears to be an important risk factor for diabetic micro- and macrovascular complications.

Sarah Craus il 17/05/2023

The foot in diabetes - a reminder of an ever-present risk

Clin Med (Lond). 2023 May;23(3):228-233. doi: 10.7861/clinmed2022-0489. Epub 2023 May 17.ABSTRACTThe term 'diabetic foot disease' (DFD) often signifies the presence of foot ulceration and infection, but one must also be wary of the rarer occurrence of Charcot foot disease. The worldwide prevalence o